Delivery Order SPE2DB20D1109-SPE2DB20FN35H
- Not listed
- This federal contract award is for a Prime Vendor Pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,386.15, was awarded by the Defense Logistics Agency (DLA) and is for the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery Order under an Indefinite Delivery Contract...
- This federal contract award is for a prime vendor pharmaceutical contract from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,753.30 firm fixed-price delivery order supports the supply of a wide range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines, to military treatment facilities, veterans' healthcare programs,...
- This federal contract award is for a prime vendor pharmaceutical distribution contract with the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $2,678.55 delivery order to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,273.45 delivery order was issued by the Defense Logistics Agency (DLA) for pharmaceutical and medical supply products to support military treatment facilities and veterans' healthcare programs. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as a primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a $2,887.65 delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a prime vendor pharmaceutical supply contract with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,231.20, covers the delivery of a wide range of pharmaceutical products, medical supplies, and equipment to support military and veterans' healthcare programs. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
- This federal contract award is for a prime vendor pharmaceutical distribution contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,305.91, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with the Defense Logistics Agency (DLA). The contract, valued at $98,877.10, is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. The contract covers the delivery of a wide range of pharmaceutical...
- This federal contract award is for a prime vendor pharmaceutical supply contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,108.29, was awarded by the Defense Logistics Agency (DLA) and is for the delivery of a broad range of pharmaceutical products, medical supplies, and equipment to support military and veterans' healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 16, 2021. The...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,930.44 delivery order was issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB20FN35HDelivery Order
This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Defense Logistics Agency (DLA) awarded this $2,653.20 firm fixed-price delivery order under the company's larger $999,999,999 Indefinite Delivery Contract (IDC) for pharmaceutical and medical supply distribution to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract covers a range of essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. There was no set-aside designation, indicating full and open competition. This contract award demonstrates Amerisourcebergen's role as a critical supplier of pharmaceutical and medical products to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/24/20 |